CTMX
CytomX TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
The constructive case is that March data and management commentary kept Varseta-M positioned as the core value driver, with FDA interaction targeted for mid-2026, additional follow-up data in 2026, and a newly bolstered capital base after the March equity raise [#PR-2026-03-16] [#8-K-2026-03-19].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -0.4.
What can break
2025 revenue declined as collaboration obligations rolled off or progressed differently, highlighting dependence on partners and making internal pipeline execution more important [#PR-2026-03-16].
Momentum
47
Value
51
Sentiment
81
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.80 · Bull $7.00 · Bear $2.60
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-05 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $12.50
Why
Momentum47 · Δ7d +56.7
Value51 · Δ7d +0.1
Sentiment81 · Δ7d -0.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
47
26% active weight
Current posture
7d trendImproving
Δ7d
+56.7
Δ21d
+65.8
Value
51
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.6
Sentiment
81
34% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-10.5
Why this grade
Composite grade A. Momentum 47.2 / Value 51.2 / Sentiment 80.9
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$766.31M
Beta
2.44
Shares Out
217.7M
P/E (TTM)
10.2
P/S (TTM)
6.14
P/FCF (TTM) · Derived
-7.07
Rev YoY
-79.9%
EPS YoY
-138.1%
Gross Margin
+96.5%
Op Margin
+20.5%
Net Debt
-$132.81M
Current Ratio
10.38
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology